|Save ComparisonClear all|
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
SemaThera is a spin-off company focusing on SEMA 3A inhibitors in the treatment of ocular diseases.
Modulating the skin microbiome to treat skin disease.
PDC Line Pharma
PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.
Elysium Health offers revolutionary health products that are built with science.
Cambridge, US HQ
Montreal-West, CA HQ
Farmington, US HQ
Grenoble, FR HQ
New York, US HQ
Twitter followers7.3 k
Latest funding round
Latest funding round$ 3.2m (over 5 years ago)
Latest funding round$ 1m (almost 2 years ago)
Latest funding round$ 2.9m (over 1 year ago)
Latest funding round$ 4.3m (almost 2 years ago)
Latest funding round$ 22m (almost 2 years ago)
Total funding raised
Total funding raised$ 3.2m
Total funding raised$ 1m
Total funding raised$ 3.3m
Total funding raised$ 4.3m
Total funding raised$ 28.2m